Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Equity Average (2018 - 2025)

Historic Equity Average for Novartis Ag (NVSEF) over the last 7 years, with Q1 2025 value amounting to $22.4 billion.

  • Novartis Ag's Equity Average changed N/A to $22.4 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $22.4 billion, marking a year-over-year change of. This contributed to the annual value of $45.3 billion for FY2025, which is 22.12% down from last year.
  • Latest data reveals that Novartis Ag reported Equity Average of $22.4 billion as of Q1 2025.
  • In the past 5 years, Novartis Ag's Equity Average ranged from a high of $34.4 billion in Q1 2022 and a low of $842.0 million during Q2 2023
  • In the last 4 years, Novartis Ag's Equity Average had a median value of $25.7 billion in 2021 and averaged $19.6 billion.
  • Its Equity Average has fluctuated over the past 5 years, first surged by 1834.51% in 2022, then crashed by 1230.74% in 2023.
  • Quarter analysis of 4 years shows Novartis Ag's Equity Average stood at $913.0 million in 2021, then surged by 3663.58% to $34.4 billion in 2022, then tumbled by 97.55% to $842.0 million in 2023, then surged by 2565.8% to $22.4 billion in 2025.
  • Its Equity Average was $22.4 billion in Q1 2025, compared to $842.0 million in Q2 2023 and $30.1 billion in Q1 2023.